Cockrell Group
Long only, deep value, value, growth at reasonable price

Bacterin International: Removal Of Overhangs Suggest New Opportunity For Investors

Summary and Recommendation

We reiterate our positive outlook on Bacterin International Holding, Inc. (NYSE MKT: BONE) shares given the company's recent hiring of new CEO Dan Goldberger and the satisfactory resolution of recent overhangs associated with the FDA and OIG inquiries.

Bacterin develops bone graft materials and biologic allografts for transplantation. The Company also develops bioactive coating technologies for implantable devices

Over the past 12 months shares of Bacterin International Holdings (NYSE MKT: BONE) have been under intense pressure having fallen from its highs of $1.82 to now below $0.60. The company has been wrought with a series of negative headlines from missing guidance, warning letters from the FDA, subpoena from the OIG and the departure of their Founder,...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details